Company / Depreciation & Amortization
Cartesian Therapeutics, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.2M
FY2025
5-year range
$600.0K / $1.2M
FY2021-FY2025
Trend
+71.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $600,000 to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +3.7%.
Increased from $600,000 to $1M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +26.0%
- 5-Year CAGR
- +3.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +3.7%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 71.4% year-over-year.
- Lowest depreciation & amortization in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2M | +71.4% |
| FY2024 | $700.0K | +16.7% |
| FY2023 | $600.0K | +0.0% |
| FY2022 | $600.0K | -14.3% |
| FY2021 | $700.0K | -30.0% |
| FY2020 | $1.0M | +33.3% |
| FY2019 | $750.0K | -13.2% |
| FY2016 | $864.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026